EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of prostate cancer bone metastasis related genes and potential therapy targets by bioinformatics and in vitro experiments

Haiyang Jiang iD, Mingcheng Liu, Yingfei Deng, Chongjian Zhang, Longguo Dai, Bingyu Zhu, Yitian Ou, Yong Zhu, Chen Hu, Libo Yang, Jun Li, Yu Bai und 1 weitere

Journal of Cellular and Molecular Medicine · 2024-08 · 28 (15)

DOI: 10.1111/jcmm.18511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 04.08.2024. Verfasst von Haiyang Jiang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology I, The Third Affiliated Hospital of Kunming Medical University (Peking University Cancer Hospital Yunnan, Yunnan Cancer Hospita…. Hauptthemen laut MEDLINE: Bone Neoplasms, Prostatic Neoplasms, Computational Biology, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Center Climbing Fund, Scientific Research Fund of Education Department of Yunnan Province, The applied basicresearch project of yunnan province-kunming medical university joint fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aetiology of bone metastasis in prostate cancer (PCa) remains unclear. This study aims to identify hub genes involved in this process. We utilized machine learning, GO, KEGG, GSEA, Single‐cell analysis, ROC methods to identify hub genes for bone metastasis in PCa using the TCGA and GEO databases. Potential drugs targeting these genes were identified. We validated these results using 16 specimens from patients with PCa and analysed the relationship between the hub genes and clinical features. The impact of APOC1 on PCa was assessed through in vitro experiments. Seven hub genes with AUC values of 0.727–0.926 were identified. APOC1, CFH, NUSAP1 and LGALS1 were highly expressed in bone metastasis tissues, while NR4A2, ADRB2 and ZNF331 exhibited an opposite trend. Immunohistochemistry further confirmed these results. The oxidative phosphorylation pathway was significantly enriched by the identified genes. Aflatoxin B1, benzo(a)pyrene, cyclosporine were identified as potential drugs. APOC1 expression was correlated with clinical features of PCa metastasis. Silencing APOC1 significantly inhibited PCa cell proliferation, clonality, and migration in vitro. This study identified 7 hub genes that potentially facilitate bone metastasis in PCa through mitochondrial metabolic reprogramming. APOC1 emerged as a promising therapeutic target and prognostic marker for PCa with bone metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsProstatic NeoplasmsComputational BiologyGene Expression Regulation, NeoplasticCell ProliferationHumansMaleCell Line, TumorBiomarkers, TumorCell MovementGene Expression ProfilingGene Regulatory NetworksPrognosis

Stichwörter der Autor:innen

bone metastasiscell communicationhub genesmachine learningprostate cancersingle cell analysis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology I, The Third Affiliated Hospital of Kunming Medical University (Peking University Cancer Hospital Yunnan, Yunnan Cancer Hospital, Cancer Center of Yunnan Province), Kunming, Yunnan, China.
  • Department of Urology II, The second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
  • Department of Human Cell Biology and Genetics, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
  • Pathology-Department, The Third Affiliated Hospital of Kunming Medical University (Peking University Cancer Hospital Yunnan, Yunnan Cancer Hospital, Cancer Center of Yunnan Province), Kunming, Yunnan, China.

ORCID-Profile: Haiyang Jiang

Förderung

  • National Cancer Center Climbing Fund
  • Scientific Research Fund of Education Department of Yunnan Province
  • The applied basicresearch project of yunnan province-kunming medical university joint fund
  • National Natural Science Foundation of China

Zitieren

APA

Jiang, H., Liu, M., Deng, Y., Zhang, C., Dai, L., Zhu, B., Ou, Y., Zhu, Y., Hu, C., Yang, L., Li, J., Bai, Y., & Yang, D. (2024). Identification of prostate cancer bone metastasis related genes and potential therapy targets by bioinformatics and in vitro experiments. Journal of Cellular and Molecular Medicine, 28(15). https://doi.org/10.1111/jcmm.18511

Vancouver

Jiang H, Liu M, Deng Y, Zhang C, Dai L, Zhu B, et al. Identification of prostate cancer bone metastasis related genes and potential therapy targets by bioinformatics and in vitro experiments. Journal of Cellular and Molecular Medicine. 2024;28(15). doi:10.1111/jcmm.18511

BibTeX
@article{Jiang2024,
  author = {Jiang, Haiyang and Liu, Mingcheng and Deng, Yingfei and Zhang, Chongjian and Dai, Longguo and Zhu, Bingyu and Ou, Yitian and Zhu, Yong and Hu, Chen and Yang, Libo and Li, Jun and Bai, Yu and Yang, Delin},
  title = {Identification of prostate cancer bone metastasis related genes and potential therapy targets by bioinformatics and in vitro experiments},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  volume = {28},
  number = {15},
  doi = {10.1111/jcmm.18511}
}
Kostenlos starten →